Ohtuvayre (ensifentrine)
- Region
- 🇪🇺 EU
- Active substance
- ensifentrine
- Company
- Verona Pharma Ireland Limited
- Status
- Application withdrawn
- Therapeutic area
- Pulmonary Disease, Chronic Obstructive
- Application
- EMEA/H/C/006742
- ATC
- R03BX
- Official record
- www.ema.europa.eu
Indication
Maintenance treatment in symptomatic adult patients with chronic obstructive pulmonary disease (COPD).
Regulatory milestones
Thu 30 Oct 2025🇪🇺 Application withdrawn (EU)
Ohtuvayre (ensifentrine): EU application withdrawn
Follow Ohtuvayre
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.